Showing results (221-230 of 406) with videos related to

Sort By:
Pageof 41
Heart (British Cardiac Society)|January 20, 2026
Effects of exercise training in left ventricular assist device patients: a systematic review with an individual participant data meta-analysisTim Kambič, Anna Feuerstein, Tim Friede, et al.
Statistical Methods in Medical Research|February 8, 2024
A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS IIAmra Pepić, Maria Stark, Tim Friede, et al.
JAMA Network Open|August 7, 2020
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial ResultsMuhammad Shahzeb Khan, Gregg C Fonarow, Tim Friede, et al.
Pediatric Dermatology|September 30, 2005
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label studyDoris Staab, David Pariser, Alice B Gottlieb, et al.
Arthritis Care & Research|December 17, 2013
Design and development of a decision support package for low back painShilpa Patel, Anne Ngunjiri, Harbinder Sandhu, et al.
Brain, Behavior, and Immunity|June 21, 2024
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progressionSönke von Drathen, Stefan Michael Gold, Julia Peper, et al.
NPJ Primary Care Respiratory Medicine|December 22, 2021
Acute respiratory infections in an adult refugee population: an observational studyAlexandra Jablonka, Christian Dopfer, Christine Happle, et al.
European Journal of Heart Failure|January 29, 2025
Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failureStefan D Anker, Tim Friede, Javed Butler, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Pageof 41